Search Results - "Owley, Thomas"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
  2. 2

    Treatment of individuals with autism spectrum disorders in the emergency department: Special considerations by Owley, Thomas B.

    “…Because of their particular difficulties in social interactions and language and communication, individuals with autism spectrum disorders (ASDs) present to…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Escitalopram pharmacogenetics: CYP2C19 relationships with dosing and clinical outcomes in autism spectrum disorder by Bishop, Jeffrey R, Najjar, Fedra, Rubin, Leah H, Guter, Stephen J, Owley, Thomas, Mosconi, Matthew W, Jacob, Suma, Cook, Edwin H

    Published in Pharmacogenetics and genomics (01-11-2015)
    “…BACKGROUND AND AIMSelective serotonin reuptake inhibitors such as escitalopram are commonly used to treat patients with autism spectrum disorder (ASD), but…”
    Get full text
    Journal Article
  7. 7

    A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders by Owley, Thomas, Salt, Jeff, Guter, Stephen, Grieve, Adam, Walton, Laura, Ayuyao, Nelson, Leventhal, Bennett L, Cook, Jr, Edwin H

    “…This pilot study examined the effectiveness of memantine hydrochloride in improving cognitive functioning and behavioral symptoms in children with pervasive…”
    Get more information
    Journal Article
  8. 8

    Pharmacogenetic Study of Serotonin Transporter and 5HT2A Genotypes in Autism by Najjar, Fedra, Owley, Thomas, Mosconi, Matthew W, Jacob, Suma, Hur, Kwan, Guter, Stephen J, Sweeney, John A, Gibbons, Robert D, Cook, Edwin H, Bishop, Jeffrey R

    “…The purpose of this study was to determine whether polymorphisms in the serotonin transporter (SLC6A4) and serotonin-2A receptor (HTR2A) genes are associated…”
    Get more information
    Journal Article
  9. 9

    An Open-Label Trial of Escitalopram in Pervasive Developmental Disorders by Owley, Thomas, Walton, Laura, Salt, Jeff, Guter, Stephen J., Jr, Winnega, Marrea, Leventhal, Bennett L, Cook, Edwin H., Jr

    “…Objective: To assess the effect of escitalopram in the treatment of pervasive developmental disorders (PDDs). Method: This 10-week study had a forced…”
    Get more information
    Journal Article
  10. 10

    A pharmacogenetic study of escitalopram in autism spectrum disorders by Owley, Thomas, Brune, Camille W., Salt, Jeff, Walton, Laura, Guter, Steve, Ayuyao, Nelson, Gibbons, Robert D., Leventhal, Bennett L., Cook, Edwin H.

    Published in Autism research (01-02-2010)
    “…Objective: To determine the effect of serotonin transporter polymorphism promoter region (5‐HTTPLR) genotypic variation (low, intermediate, and high expression…”
    Get full text
    Journal Article
  11. 11

    Utility of the Gilliam Autism Rating Scale in Research and Clinical Populations by South, Mikle, Williams, Brenda J, McMahon, William M, Owley, Thomas, Filipek, Pauline A, Shernoff, E, Corsello, Christina, Lainhart, Janet E, Landa, Rebecca, Ozonoff, Sally

    “…A study examined the validity of the Gilliam Autism Rating Scale (GARS) with 119 children (ages 3-10) with strict DSM-IV (Diagnostic Statistical Manual of…”
    Get full text
    Journal Article
  12. 12

    Multisite, double-blind, placebo-controlled trial of porcine secretin in autism by Owley, T, McMahon, W, Cook, E H, Laulhere, T, South, M, Mays, L Z, Shernoff, E S, Lainhart, J, Modahl, C B, Corsello, C, Ozonoff, S, Risi, S, Lord, C, Leventhal, B L, Filipek, P A

    “…To examine the efficacy of intravenous porcine secretin for the treatment of autistic disorder. Randomized, double-blind, placebo-controlled, crossover design…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Impact of recent findings on study design of future autism clinical trials by Hollander, Eric, Phillips, Ann, King, Bryan H, Guthrie, Donald, Aman, Michael G, Law, Paul, Owley, Thomas, Robinson, Ricki

    Published in CNS spectrums (01-01-2004)
    “…There are specific challenges to studying the design of pharmacologic trials in child/adolescent and adult autism, such as subject stratification and parallel…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Case series: Adderall augmentation of serotonin reuptake inhibitors in childhood-onset obsessive compulsive disorder by Owley, Thomas, Owley, Soyna, Leventhal, Bennett, Cook, Jr, Edwin H

    “…Current pharmacological treatment of obsessive compulsive disorder involves the use of selective serotonin reuptake inhibitors (SSRIs). However, a large…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19